E
Edward Giovannucci
Researcher at Harvard University
Publications - 1819
Citations - 202335
Edward Giovannucci is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 206, co-authored 1671 publications receiving 179875 citations. Previous affiliations of Edward Giovannucci include University of California, San Francisco & American Cancer Society.
Papers
More filters
Journal ArticleDOI
Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study.
Xia Jiang,Niki Dimou,Kawthar Al-Dabhani,Sarah J Lewis,Richard M. Martin,Philip C Haycock,Marc J. Gunter,Timothy J. Key,Rosalind A. Eeles,Rosalind A. Eeles,Kenneth Muir,David E. Neal,Graham G. Giles,Edward Giovannucci,Edward Giovannucci,Meir J. Stampfer,Meir J. Stampfer,Brandon L. Pierce,Joellen M. Schildkraut,Shaneda N. Warren Andersen,Deborah J. Thompson,Wei Zheng,Peter Kraft,Konstantinos K. Tsilidis +23 more
TL;DR: The MR analysis does not support a causal effect of circulating 25(OH)D concentrations on breast- or prostate-cancer risk, and future studies may be designed to understand the effect of vitamin D in subpopulations with a profound deficiency.
Journal ArticleDOI
A Prospective Cohort Study of Nut Consumption and the Risk of Gallstone Disease in Men
TL;DR: It is suggested that frequent nut consumption is associated with a reduced risk of gallstone disease in men after adjustment for age and other known or suspected risk factors.
Journal ArticleDOI
Pre-hospital Vitamin D Concentration, Mortality, and Bloodstream Infection in a Hospitalized Patient Population
Nancy E. Lange,Augusto A. Litonjua,Fiona K. Gibbons,Edward Giovannucci,Kenneth B. Christopher +4 more
TL;DR: Analysis of 23,603 hospitalized patients identified both 25(OH)D ≤15 ng/mL and 25( OH)D 15 to 30 ng/ mL before hospital admission as associated with the odds of all-cause patient mortality at 30 days after hospitalization.
Journal ArticleDOI
MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer.
Ruoxu Dou,Ruoxu Dou,Reiko Nishihara,Yin Cao,Tsuyoshi Hamada,Kosuke Mima,Atsuhiro Masuda,Yohei Masugi,Yan Shi,Mancang Gu,Wanwan Li,Annacarolina da Silva,Katsuhiko Nosho,Katsuhiko Nosho,Xuehong Zhang,Jeffrey A. Meyerhardt,Edward Giovannucci,Andrew T. Chan,Andrew T. Chan,Charles S. Fuchs,Charles S. Fuchs,Zhi Rong Qian,Shuji Ogino,Shuji Ogino +23 more
TL;DR: The population-based data presented in this study support a possible role for microRNA let-7a in the suppression of antitumor immunity in colorectal cancer patients and suggest let- 7a as a potential target of immunotherapy.
Journal ArticleDOI
Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer
Mai Yamauchi,Paul Lochhead,Yu Imamura,Aya Kuchiba,Xiaoyun Liao,Zhi Rong Qian,Reiko Nishihara,Teppei Morikawa,Kaori Shima,Kana Wu,Edward Giovannucci,Jeffrey A. Meyerhardt,Charles S. Fuchs,Andrew T. Chan,Shuji Ogino +14 more
TL;DR: Immunohistochemical PTGS2 expression in colorectal carcinoma may serve as a predictive biomarker in pathology practice, which may predict stronger benefit from exercise.